This paper reviews problems with the definition and estimation of interactions in epidemiologic studies. Methods for modeling interactions and dose-response also are reviewed, and references to more detailed literature are provided. Concepts are illustrated in the context of evaluating the joint effects of household radon exposure and environmental tobacco smoke. -Environ Health Perspect 101 (Suppl 4): 59-66 (1993).
Introduction
In any study of the health effects of exposure mixtures, it is natural to ask whether or not observed effects are due to interactions of the mixtures' components; for example, one may inquire whether or not the effect of one component is modified by the effect of another (effect modification). Four major problems in addressing such a question are: a) The term "interaction" has no single definition but requires precise definition in order to be studied; b) even when it is precisely defined, there is often little study power to detect interaction; c) interactions are inevitably confounded with dose-response and latency relationships; and d) measurement errors, even if independent and nondifferential (random), may severely distort interaction assessment. This paper reviews these four problems and provides references to detailed literature on the problems. Definitions of the central concepts are reviewed first in order to provide a basis for precise problem statements. Next, the problems are described and illustrated in the context of evaluating effects of household radon exposure and environmental tobacco smoke (passive smoking). Finally, methods for dealing with the problems are reviewed.
Issues concerning mechanisms of interaction are not addressed here. As recently discussed by Thompson 
Definitions Main EfHec and Causal Effects
A source of ambiguity in the study of interactions (and indeed in the study of any effects) is the existence of multiple definitions of the term effect. Two major definitions exist. Ironically, both seem to have developed from the pioneering work on experimental design conducted by Fisher, Neyman, and others during the period between the first and second world wars.
The first definition, the parametric definition, is by far the most common today: An effect is a coefficient of a study exposure in a generalized linear model for the outcome of interest. [A generalized linear model is simply a linear model for some transformation of the expected outcome (2) .] As an example, consider a log-linear (multiplicative) model for the rate R (in cases per person-year) of lung cancer in a cohort of married nonsmokers, given a certain exposure to spousal tobacco smoke x and radon level z, within a stratum k defined by some combination of age, sex, and (possibly) other determinants of lung cancer: logeRk= =ak + Px +yz [la] or, equivalently, Rk, = exp(ak + Px+Yz). [lb] Here, k = 1, 2, 3,... simply indexes the various strata created by subdividing the cohort into subcohorts homogeneous on age, sex, etc., and ak represents the log rate among stratum-k subjects who have no smoke or radon exposure (x = 0 and z = 0).
The coefficients and y of x and z traditionally are called the main effects of smoke and radon. This term suggests that and y represent some sort of causal action of smoke and radon on lung cancer rates. Such an interpretation could, however, be misleading. For (5) ; another line of development was introduced into epidemiology by Rothman (6) . In the ensuing decade, epidemiologists have employed counterfactual models to define biological interactions (7) (8) (9) , confounding (10) , and intermediate effects (11, 12) .
The present discussion ignores the problem of competing risks, that is, outcome events that remove a subject from risk of the outcome of interest. For lung cancer, all such competing risks are deaths from other causes, such as a car crash. Proper conceptualization of competing risks in a causal framework is somewhat controversial (13, 14) . To [3] among subjects with one pack-decade of spousal-smoke exposure but no radonprogeny exposure, Rkol = exp(ak + 0.693) = 2.Oexp(ak) [4] among subjects with no spousal-smoke exposure but 100 WLM radon-progeny exposure, and RkIl = exp(ak+ 0.182 + 0.693) = 2.4exp(cXk) [5] among subjects with one pack-decade of spousal-smoke exposure and 100 WLM radon-progeny exposure. When expressing these four rates in the format of a linear excess-rate-ratio model R = (1 + P*x+ y*z+ 8*xz)exp(ak), [6] one finds that Rklo= 1.2exp(ak) = (1 + P*)exp(ak), [7] Rkol = 2.Oexp(ak) = (1 + Y)exp(ak), [8] and Rkll = 2.4exp((ak) = (1 + ,B* + y* + *)exp(ak). [9] The rate among the unexposed, exp(ak), can- 
Connections among Definitions ofEffects and Interaction
The definition of coaction just given bears no resemblance to the statistical definition of interaction; in particular, the concept of coaction is connected only indirectly to the statistical model for the rates. In terms of incidence time, the definition of coaction conflicts with the common definition of synergy as a total effect greater than the sum of the separate effects: In the example, the advance of lung-cancer time when both exposures are present (30 years) is less than the sum of the advance when only radon is present (85 -70 = 15 years) and the advance when only smoke is present (85 -65 = 20 years). Nevertheless, there is a connection among these concepts when the problem is reformulated in terms ofincidence proportions (i.e., average risks ofdisease).
As an illustration of this connection, consider the subcohort of male nonsmokers whose exposure histories (up to the time they contract lung cancer) are, say, RDxo(t) = Rxo(t) -Roo(t) (radon) [10] and RDoz(t) = Roz(t) -R&o(t) (smoke) [1 1] which are entirely counterfactual, and a difference that measures their actual combined effect, RDxz(t) = Rxz(t) -R0o(t). [12] It can be shown that superadditivity of the differences, RDXZ(t) > RDxo(t) + RDoz(t) [13] can occur only if, in some subjects, radon and smoke causally interact in some of the cohort members; that is, only if coaction has occurred in some members (8, 9) . Note, however, that the converse is not true: Coaction may take place without superadditivity occurring (8, 9) .
It follows that an upper one-sided test of the additivity condition RDxz(t) = RDxo(t) + RDoz(t) [14] may be regarded as a test for the occurrence of coaction. Various forms of this conclusion, and tests of additivity (model 14) as a test for synergism, can be found in the pharmacology literature as far back as the 1920s (18) . The idea did not seem to attract notice in the epidemiologic literature until the 1970s; see Rothman (15) , Koopman (7), and Miettinen (8) for some early formulations. Inequality 13 conforms to the common notion of synergy as a combined effect exceeding the sum of separate effects; note, however, that the effect referred to here is the effect of the exposures on an entire, homogeneously exposed subcohort. In contrast, the effect referred to in the definition of coaction refers to a single subject.
Inequality 13 also conforms to the definition of statistical interaction if one adopts an additive model for the average risks. To see this, define a(t) = Roo(t), (x,t) = RDxO(t),y(zt) = RDoz(t), [15] and 6(x;z,t) = [RD,.(t) -RD,o(t) -RD0z(t)]. [16] Then, with a little algebra, we see that inequality 13 implies Rx,(t) = a(t) + P(x,t) + y(z,t) + 3(x,Z;t) with 6(x,z,t)>0. [17] Thus, as before, superadditivity of effects (in particular, an additive-risk model with two causal exposures and a positive product term) implies the presence of interaction. Although the counterfactual and statistical definitions do not otherwise coincide, the superadditive case is, fortunately, the one of primary concern in the study of environmental and occupational hazards, for it is this case that is usually of most public-health concern (16, 17 (23) .
Situations involving continuous exposure measurements are considerably more complex, but nevertheless reveal that considerably larger study sizes are needed to study interactions than are required to detect effects (24) . We will return to this issue in the discussion of designs for the study of interactions.
Confounding ofIntaction and Dose-Response
In common epidemiologic usage, dose-response refers to the changes in risk produced by changes in a single exposure, whereas interaction refers to changes in risk produced by two or more exposures. Thomas (25) (27) . Similar problems will arise if accuracy of outcome measurement (e.g., disease diagnosis) varies over time.
The Impact ofMeasurement Errors (29) . Lubin et al. (25) specifically consider models for radon measurement to evaluate the impact of measurement errors in studies of tobacco smoke, radon, and lung cancer.
The impact of measurement errors on interaction estimates has been studied less thoroughly. Independent nondifferential classification errors can produce spurious appearances of interaction and can mask true interactions, depending on other features of situation (19) . More independent of x, z, and each other), or if the errors were independent, nondifferential, and x and z were not associated with each other (Appendix).
The distortion ofdose-response and interaction estimates produced by measurement error depends heavily on the particulars of the study distribution ofexposures and errors. Thus, rather than rely on any general (and possibly misleading) conclusions, it may be best to evaluate the effects of measurement error on a study-specific basis, using methods of the sort discussed in the next section. In the particular case ofenvironmental tobacco smoke and radon, measurement errors may render the study ofinteractions infeasible due to attenuated power (24); a similar conclusion may apply to most other epidemiologic studies of environmental exposures.
Coping with the Problems Designs for Assessing Intracons and Dose-Response
In studies involving primary subject selection, power for detection of interactions can be increased by using special sampling plans. Unfortunately, a major obstade in employing such designs is that they require a priori specification of a number of parameters that may be only vaguely known, if at all. For cohort studies, one must be able to specifyj likely values for the intercept and main-effect parameters (e.g., a, P, y in model 18) in the model of interest, as well as a value for the interaction parameter (6) for which one wishes to maximize power or precLsion. For case-control studies, the intercept need not be specified, but one must have some idea of the exposure distributions in the population serving as the source ofcases and controls.
A considerable amount of literature exists for choosing optimal designs, at least in the cohort framework; Seber and Wlld (30) provide references to the linear-model literature and also review design methods for nonlinear models. Although this literature is highly technical, a few general condusions can be drawn, especially in the special case of studying departures from risk or rate additivity.
The optimal design for detecting departures from additivity will not correspond to the optimal design for detecting departures from linearity of the dose-response curve for each exposure. Nor will either of these designs correspond to the optimal design for detecting main effects; however, the presence of main effects will hopefully have been established before embarking on a specialized study of interactions.
Because one will have to simultaneously consider interaction and dose-response, as explained earlier, it may be best to select subjects to maximize precision of the estimated dose-response surface. In this approach, interaction represents but one of several potentially important departures from linearity of the joint dose-response surface relating smoke (x) and radon (z) to risk. For example, consider the quadraticrisk model given in model 19. A good design for studying such a model would select subjects to enhance the precision of estimates for 02 and y2 as well as 6.
More generally, one would want to allow for response surfaces other than quadratic, including perhaps unanticipated shapes. One simple cohort design to help achieve this end would try and insure that subjects are distributed evenly across the joint range of smoke and radon levels (that is, across the combinations of x and z).
The case-control situation is not addressed as easily, for it is the case-control ratio rather than the joint exposure distribution that is controlled by the investigator. Nevertheless, if one is willing to sacrifice the ability to estimate the main effect of one of the exposures, one also may manipulate the marginal distribution of that exposure by, for example, case-control matching; see Smith and Day (31) and Thomas and Greenland (32) for some elementary studies of the impact of matching on interaction assessment in the context of log-linear interactions. For interaction assessment, one can expect that certain highly variable matching ratios will offer more precision than fixed ratios: Relatively few controls per case would be needed in strata with many cases, but relatively many controls per case would be needed in strata with few cases.
If one already knows the joint distribution ofdisease and one ofthe exposures in the source population, it may be most efficient to employ a two-stage design rather than a conventional matched design; see Cain and Breslow (33) (34) . As an example, the generalized-additive analogue of model 1 would be log1(R,.) = ak + (x) + Y(z), [20] where 5(x) and y(x) are now unspecified functions of x and z that will be estimated from the data. Unlike model 1, which constrains dose-response to be log linear, model 20 allows the dose-response for smoke and radon to be any shape at all. Both models 1 and 20 do, however, imply that the shape for the smoke dose-response does not change across levels of radon or covariates, and the shape for the radon dose-response does not change across levels of smoke or covariates; this set of constraints is called the no-additive-interaction or parallelism condition. Model 20 is easily fit using the GAIM software package (35) . To generalize model 20 to allow for departures from additivity, one may add a product-term function to obtain log,(Rxz) = ak 3(x) + Y(z) + 6(xz). [21] This is one ofseveral possible generalized-additive analogues of model 1. Unlike model 20, it does not constrain the dose-response surface to contain parallel dose-response curves.
All the models given so far imply that the shape of the dose-response surface does not change across the covariate strata (i.e., there is no additive interaction with covariates). To Further extensions of the above models may be obtained by considering other transformations of the outcome measure, as in the additive logit model in which logitRk,z = ak + (x) + Y(z), [22] where logit R = log,[RI(1-R)]. One also may employ incidence times or rates in place of risks as the outcome measure in the above models. The (29) . If the study variables are discrete, matrix formulas for correcting contingency-table results can be applied (40, Appendix) , and these are programmed easily in matrix languages such as GAUSS, SC, S-PLUS, and SAS IML.
Conclusions
Given the difficulties inherent in attempting to study interactions with epidemiologic data, design and analysis is best focused on accurate estimation of the entire dose-response surface relating incidence to covariates, rather than on isolated aspects of this surface, such as statistical interaction. One may, of course, test the departure of the data from surfaces predicted by various causal models, such as the no-coaction model (7, 9) or the simple independent-action model (44) , but the power and validity of these tests will be nearly optimal under the same conditions that insure accuracy of dose-response estimation, such as well-balanced exposure distributions and accurate exposure measurement.
will help achieve the most accurate assessment of interaction possible with available data. Nevertheless, because of limitations of power and because of distortions produced by measurement error, one should be cautious about the potential of environmental epidemiology for interaction assessment.
Appendix
For simplicity, suppose we have just one stratum, and let P(x,y xm,zm) be the probability that a subject with measured smoke and radon exposures xm and Zm has true levels x and z; note that 4,,P(x,y x.,z.) = 1 (here, X,. indicates the sum over all possible values ofx and z). Let .i(Xm,Zm.) )-X xP(x,y Xm,Zm,) and z (Xm,Zm)-X zP(x,y xmz,m) [23] be the means ofthe true smoke and radon levels among subjects with measured levels xm and zm; let R.,z be the average risk among subjects with true levels x and z; and suppose Rxz follows the no-interaction linear-risk model (model 18 with 6 = 0). Then the average risk among subjects with measured levels xm and zm will be R (Xm,Zm ) = Xz P (x,Z I Xm,Zm) R. = ,z P(X,ZI Xm,Z.) ( [25] in contrast, for subjects measured as exposed to only one of the two exposures, we have [26]
Thus, except in certain special cases, RD(xm,zm) . RD(X.,O) + RD(O,Zm). [27] that is, the risks based on the measured exposures need not be additive, and this is so even if the measurement error is independent and nondifferential and the risks based on the true exposures are additive. Additivity will be preserved (i.e., 25 [29] This would occur, for example, if the errors were independent nondifferential and x and z were unassociated, or if x and z were bivariate normal and their respective errors were independent normal with homogeneous variance. Additivity also will be preserved under "Berkson error" [see Armstrong (29) for discussion of Berkson error in the context ofmain-effect estimates]. 
